Form D · Pharmaceuticals

Land Therapeutics Inc.

Charlestown, MA · CIK 0002051104

Offering snapshot reported Oct 21, 2026 · SEC filing

Reported sold
$17.5M
Offering amount: $92.1M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 23, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$8.76M$17.5MJan 7, 2025: $16,911,616.00Jan 7, 2025Oct 21, 2026: $17,511,614.00Oct 21, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,911,616 → $17,511,614

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 21, 2026Amendment$17,511,614$599,998vs Jan 7, 202512SEC filing
Jan 7, 2025Initial$16,911,616No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-534440
Total amount sold includes $911,624.12 of cancellation of indebtedness and $16,599,989.86 of new cash.

Source: Form D, filed Oct 21, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joe Cabral Director
Tony Ho Director, Executive
Rob Hopfner Director
Andy May Director
Dan Peer Director
Timothy Shannon Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
21 Pier 7
Charlestown, MA, 02129